logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Combinatorx, Incorporated

Calculating rank
USPTO Granted Patents = 10

% Expired Patents = 90.0

Forward Citations = 203

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Curtis Keith (9 out of 11 patents)

silverMedal Alexis Borisy (8 out of 14 patents)

bronzeMedal Michael Andrew Foley (5 out of 14 patents)

4.  Edward Roydon Jost-Price (5 out of 7 patents)

5.  Palaniyandi Manivasakam (5 out of 8 patents)

6.  Brent R Stockwell (4 out of 25 patents)

7.  Grant R Zimmermann (4 out of 6 patents)

8.  Nicole Hurst (4 out of 6 patents)

9.  Robyn Sackeyfio (3 out of 3 patents)

10.  Jason Fong (3 out of 3 patents)

11.  Margaret S Lee (1 out of 9 patents)

12.  M James Nichols (1 out of 3 patents)

13.  Michael S Slavonic (1 out of 2 patents)

14.  Brendan Smith (1 out of 2 patents)

15.  Benjamin A Auspitz (1 out of 2 patents)


10 patents:

1. 7795310 - Methods and reagents for the treatment of metabolic disorders (2010-09-14),
2. 7709495 - Methods and reagents for the treatment of inflammatory disorders (2010-05-04),
3. 7335371 - Combinations for the treatment of inflammatory disorders (2008-02-26),
4. 7253155 - Combinations for the treatment of immunoinflammatory disorders (2007-08-07),
5. 7148216 - Combinations of drugs for the treatment of neoplastic disorders (2006-12-12),
6. 6955815 - Combinations for the treatment of inflammatory disorders (2005-10-18),
7. 6897206 - Combinations for the treatment of inflammatory disorders (2005-05-24),
8. 6846816 - Combinations of drugs for the treatment of neoplastic disorders (2005-01-25),
9. 6693125 - Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders (2004-02-17),
10. 6569853 - Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders (2003-05-27),
Company Overview
Combinatorx, Incorporated is a biotechnology company based in Cambridge, MA, specializing in the development of innovative therapeutics. The organization focuses on leveraging advanced technologies to create novel drug candidates, particularly in the fields of immunology and oncology. By employing a unique approach to drug discovery, Combinatorx aims to address unmet medical needs and enhance treatment options for patients. Their commitment to research and development positions them at the forefront of biopharmaceutical advancements.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

10 Patents

#234 in Cambridge, MA

#1,777 in Massachusetts

#29,922 in US

#56,169 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Combinatorx, Incorporated

Forward Citations = 203

18 inventors:

goldMedal Curtis Keith (9 out of 11 patents)

silverMedal Alexis Borisy (8 out of 14 patents)

bronzeMedal Michael Andrew Foley (5 out of 14 patents)

4.  Edward Roydon Jost-Price (5 out of 7 patents)

5.  Palaniyandi Manivasakam (5 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Combinatorx, Incorporated. Retrieved from https://idiyas.com/company/combinatorx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…